Eliminate Insurance Company Prior Authorization for MAT

From Media Wiki
Jump to: navigation, search

Return to Opioid Top-Level Strategy Map or the Zoom Map (Expand Access to Optimized MAT) 

Background

In a letter to the National Association of Attorneys General (NAAG), the AMA urged all attorneys general to take action and work with insurers to end prior authorization on medication-assisted treatment (MAT).[1]
  “We need to remove any and all barriers to providing care for substance-use disorders. We also urge all payers to end policies that require patients to repeat step-therapy protocols or retry therapies failed under other benefit plans before qualifying coverage of a current effective therapy for substance-use disorders.” - Dr. Madara, AMA Executive Vice President and CEO[2]
 

Current Status

  • In one survey, 90 percent of physicians reported that prior authorization delays access to necessary care.[3]
  • In one survey, nearly 60 percent reported that patient care was delayed by at least a day because of these manual, time-consuming processes.[4]
  • In October 2016 Cigna ended a requirement that prevented providers from prescribing treatments for patients with opioid addiction without prior authorization. [5]
  • In January 2017 Anthem, the nation's second largest insurance company, also ended prior authorization[6]

Tools & Resources

TR - Eliminate Insurance Company Prior Authorization for MAT

Scorecard Building

Potential Objective Details(Under Construction) 
Potential Measures and Data Sources(Under Construction) 
Potential Actions and Partners(Under Construction) 

 

Resources to Investigate

More RTI on Eliminate Insurance Company Prior Authorization for MAT

PAGE MANAGER: [insert name here]
SUBJECT MATTER EXPERT: [fill out table below]

Reviewer Date Comments
     

Sources


  1. [1]
  2. [2]
  3. [3]
  4. [4]
  5. [5]
  6. [6]
</div>